Finerenone in Patients with Focal Segmental Glomerulosclerosis
Year: 2026
Type: article
Authors: Hiddo J.L. Heerspink, Brendon L. Neuen, Rajiv Agarwal, David Z.I. Cherney, Carolyn S.P. Lam, Katherine R. Tuttle, Christoph Wanner, Pantelis Sarafidis, Glenn M. Chertow, Tim Friede, Jonathan Barratt, Jürgen Floege, Alfredo Chew-Wong, Vladimir Dobronravov, Susanne B. Nicholas, Hirokazu Okada, David Packham, Pablo E. Pergola, Marijn M. Speeckaert, Shuifu Tang, Niels Jongs, J. David Smeijer, Carolina Aldworth, Mario Berger, Meike Brinker, Rania Dayoub, Marina Yael Finkelsztein, Aidan MacNamara, Patrick Schloemer, Vlado Perkovic, for the FIND-CKD Investigators
Institutions: University Medical Center Groningen, University of Groningen, UNSW Sydney, The George Institute for Global Health, Royal North Shore Hospital, Richard L. Roudebush VA Medical Center, Indiana University School of Medicine, University Health Network, University of Toronto, Toronto General Hospital, National University of Singapore, Duke-NUS Medical School, National Heart Centre Singapore, University of Washington, University of Würzburg, Aristotle University of Thessaloniki, Ippokrateio General Hospital of Thessaloniki, Stanford Medicine, Stanford University, Universitätsmedizin Göttingen, University of Leicester, Leicester General Hospital, Universitätsklinikum Aachen, First Pavlov State Medical University of St. Petersburg, University of California, Los Angeles, Saitama Medical University, The Royal Melbourne Hospital, Renal Associates P. A., Ghent University, Guangzhou University of Chinese Medicine, Bayer (United States), Bayer (Germany), University Hospital Regensburg
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7233559704
FWCI:
Cites:
Cited by:
Related to:
